{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:23:37Z","timestamp":1792671817027,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022A1515011640"],"award-info":[{"award-number":["2022A1515011640"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.breast.2024.103737","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T08:33:48Z","timestamp":1713947628000},"page":"103737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Prediction of breast cancer and axillary positive-node response to neoadjuvant chemotherapy based on multi-parametric magnetic resonance imaging radiomics models"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4043-5968","authenticated-orcid":false,"given":"Yingyu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meizhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3390-7699","authenticated-orcid":false,"given":"Xiaoling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2024.103737_bib1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/annonc\/mdy537","article-title":"De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017","volume":"30","author":"Curigliano","year":"2019","journal-title":"Ann Oncol : official journal of the European Society for Medical Oncology"},{"key":"10.1016\/j.breast.2024.103737_bib2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamaoncol.2015.4935","article-title":"Ten-year outcomes of patients with breast cancer with cytologically confirmed axillary lymph node metastases and pathologic complete response after primary systemic chemotherapy","volume":"2","author":"Mougalian","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2024.103737_bib3","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","article-title":"Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy","volume":"23","author":"Hennessy","year":"2005","journal-title":"J Clin Oncol : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.breast.2024.103737_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.breast.2024.103737_bib5","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1245\/s10434-015-4404-8","article-title":"Pathological complete response in neoadjuvant treatment of breast cancer","volume":"22","author":"Cortazar","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2024.103737_bib6","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J Clin Oncol : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.breast.2024.103737_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10549-017-4155-2","article-title":"Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients","volume":"163","author":"Goorts","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103737_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jso.23470","article-title":"Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology","volume":"109","author":"Chen","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.breast.2024.103737_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/SLA.0000000000002953","article-title":"The clinical significance of breast-only and node-only pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT): a review of 20,000 breast cancer patients in the National cancer data Base (NCDB)","volume":"268","author":"Fayanju","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2024.103737_bib10","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2024.103737_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","article-title":"Axillary nodal management following neoadjuvant chemotherapy: a review","volume":"3","author":"Pilewskie","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2024.103737_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.6004\/jnccn.2019.0009","article-title":"NCCN guidelines insights: breast cancer, version 3.2018","volume":"17","author":"Goetz","year":"2019","journal-title":"J Natl Compr Cancer Netw : J Natl Compr Cancer Netw"},{"key":"10.1016\/j.breast.2024.103737_bib13","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1245\/s10434-015-4403-9","article-title":"Role of imaging in neoadjuvant therapy for breast cancer","volume":"22","author":"Dialani","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2024.103737_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13058-020-01350-2","article-title":"Prognostic value of (18)F-FDG PET and PET\/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis","volume":"22","author":"Han","year":"2020","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2024.103737_bib15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jamcollsurg.2017.08.027","article-title":"MRI and prediction of pathologic complete response in the breast and axilla after neoadjuvant chemotherapy for breast cancer","volume":"225","author":"Weber","year":"2017","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.breast.2024.103737_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-Update and clarification: from the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2024.103737_bib17","doi-asserted-by":"crossref","first-page":"S462","DOI":"10.1016\/j.jacr.2017.08.037","article-title":"ACR appropriateness Criteria(\u00ae) monitoring response to neoadjuvant systemic therapy for breast cancer","volume":"14","author":"Slanetz","year":"2017","journal-title":"J Am Coll Radiol : JACR"},{"key":"10.1016\/j.breast.2024.103737_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1148\/radiol.12110748","article-title":"Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657\/I-SPY TRIAL","volume":"263","author":"Hylton","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2024.103737_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13244-013-0219-y","article-title":"The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review","volume":"4","author":"Lobbes","year":"2013","journal-title":"Insights into imaging"},{"key":"10.1016\/j.breast.2024.103737_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1148\/radiol.10092021","article-title":"Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer","volume":"257","author":"Park","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2024.103737_bib21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1148\/radiol.2018180273","article-title":"Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer: the ACRIN 6698 multicenter trial","volume":"289","author":"Partridge","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2024.103737_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317694540","article-title":"Magnetic resonance imaging tumor regression shrinkage patterns after neoadjuvant chemotherapy in patients with locally advanced breast cancer: correlation with tumor biological subtypes and pathological response after therapy","volume":"39","author":"Ballesio","year":"2017","journal-title":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"10.1016\/j.breast.2024.103737_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13058-018-0950-x","article-title":"MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer","volume":"20","author":"Goorts","year":"2018","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2024.103737_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100831","article-title":"Multiparametric MRI-based radiomics analysis for the prediction of breast tumor regression patterns after neoadjuvant chemotherapy","volume":"13","author":"Zhuang","year":"2020","journal-title":"Translational oncology"},{"key":"10.1016\/j.breast.2024.103737_bib25","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1158\/1078-0432.CCR-18-3190","article-title":"Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study","volume":"25","author":"Liu","year":"2019","journal-title":"Clin Cancer Res : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.breast.2024.103737_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fonc.2020.00093","article-title":"The diagnostic performance of DCE-MRI in evaluating the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis","volume":"10","author":"Cheng","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.breast.2024.103737_bib27","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150143","article-title":"Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and 1\u2078F-FDG PET\/CT","volume":"88","author":"You","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.breast.2024.103737_bib28","doi-asserted-by":"crossref","first-page":"R150","DOI":"10.1088\/0031-9155\/61\/13\/R150","article-title":"Applications and limitations of radiomics","volume":"61","author":"Yip","year":"2016","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.breast.2024.103737_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2024.103737_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/SLA.0000000000003071","article-title":"Implications for breast cancer restaging based on the 8th edition AJCC staging manual","volume":"271","author":"Plichta","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2024.103737_bib31","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2024.103737_bib32","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.20.03399","article-title":"Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline","volume":"39","author":"Korde","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2024.103737_bib33","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.breast.2024.103737_bib34","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J Clin Oncol : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.breast.2024.103737_bib35","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2024.103737_bib36","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2024.103737_bib37","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1245\/s10434-016-5277-1","article-title":"Nomograms for predicting axillary response to neoadjuvant chemotherapy in clinically node-positive patients with breast cancer","volume":"23","author":"Vila","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2024.103737_bib38","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1245\/s10434-017-5872-9","article-title":"Preoperative prediction of node-negative disease after neoadjuvant chemotherapy in patients presenting with node-negative or node-positive breast cancer","volume":"24","author":"Murphy","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2024.103737_bib39","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1245\/s10434-018-6345-5","article-title":"A predictive model for axillary node pathologic complete response after neoadjuvant chemotherapy for breast cancer","volume":"25","author":"Kantor","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2024.103737_bib40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2214\/AJR.09.3908","article-title":"Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis","volume":"195","author":"Yuan","year":"2010","journal-title":"AJR. American journal of roentgenology"},{"key":"10.1016\/j.breast.2024.103737_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clbc.2016.12.010","article-title":"Role of magnetic resonance imaging in detection of pathologic complete remission in breast cancer patients treated with neoadjuvant chemotherapy: a meta-analysis","volume":"17","author":"Gu","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2024.103737_bib42","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1200\/JCO.2010.31.1258","article-title":"Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype","volume":"29","author":"Loo","year":"2011","journal-title":"J Clin Oncol : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.breast.2024.103737_bib43","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s00259-019-04313-8","article-title":"PET\/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy","volume":"46","author":"Antunovic","year":"2019","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.breast.2024.103737_bib44","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s00259-020-04684-3","article-title":"(18)F-FDG PET\/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients","volume":"47","author":"Li","year":"2020","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.breast.2024.103737_bib45","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1245\/s10434-013-3118-z","article-title":"Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer","volume":"20","author":"Hieken","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2024.103737_bib46","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.acra.2014.10.010","article-title":"Suspicious axillary lymph nodes identified on clinical breast MRI in patients newly diagnosed with breast cancer: can quantitative features improve discrimination of malignant from benign?","volume":"22","author":"Rahbar","year":"2015","journal-title":"Acad Radiol"},{"key":"10.1016\/j.breast.2024.103737_bib47","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s41467-020-15027-z","article-title":"Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer","volume":"11","author":"Zheng","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.breast.2024.103737_bib48","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3389\/fonc.2020.01410","article-title":"Machine learning-based radiomics nomogram using magnetic resonance images for prediction of neoadjuvant chemotherapy efficacy in breast cancer patients","volume":"10","author":"Chen","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.breast.2024.103737_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103460","article-title":"Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: a machine learning, multicenter study","volume":"69","author":"Yu","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.breast.2024.103737_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13058-022-01516-0","article-title":"Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment","volume":"24","author":"Wang","year":"2022","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2024.103737_bib51","article-title":"The mechanism of DNA methylation and miRNA in breast cancer","volume":"24","author":"Ma","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.breast.2024.103737_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100851","article-title":"Long non-coding RNA mediated drug resistance in breast cancer","volume":"63","author":"Singh","year":"2022","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.breast.2024.103737_bib53","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","article-title":"Overcoming endocrine resistance in breast cancer","volume":"37","author":"Hanker","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.breast.2024.103737_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105320","article-title":"Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications","volume":"163","author":"Zeng","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.breast.2024.103737_bib55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10549-018-4730-1","article-title":"Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients","volume":"170","author":"Chen","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103737_bib56","article-title":"Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival","volume":"32","author":"Schlotter","year":"2017","journal-title":"Horm Mol Biol Clin Invest"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977624000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977624000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T21:09:07Z","timestamp":1758834547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977624000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":56,"alternative-id":["S0960977624000687"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2024.103737","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of breast cancer and axillary positive-node response to neoadjuvant chemotherapy based on multi-parametric magnetic resonance imaging radiomics models","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2024.103737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103737"}}